The Australasian Professional Society on Alcohol and other Drugs

News & Media

Senior Lecturer (Education Focused) Addiction Studies

Closing Date Sunday 4  March, 11.55pm AEDT

Turning Point and Monash University are currently advertising a full-time level C position to coordinate the ongoing development, administration and delivery of content of our Masters of Addictive Behaviours, as well as assist with the development of related certificate and short courses. The position is a permanent full-time role, and applicants with a passion for education are encouraged to apply. The position closes on 4/3/18.The relevant web link to the job opportunity is http://careers.pageuppeople.com/513/cw/en/job/572079/senior-lecturer-education-focused-addiction-studies

0d6a2355 30b9 43c0 97b5 0aacf0bb7060
 

Insight Seminars | free for APSAD Members

To download semester one calendar click here

 

Insight Seminar Calendar 2018 Semester 1

 

Position Vacant | Specialist/Senior Specialist Addiction Medicine

Canberra Hospital and Health Services | Applications close 2 March 2018


 A growing service with exciting opportunities

  • Great location and lifestyle
  • Free parking and easy commuting
  • An attractive remuneration package will be negotiated

Mental Health, Justice Health and Alcohol & Drug Services provides health services directly and through partnerships with community organisations. The services provided range from prevention and treatment to recovery and maintenance and harm minimisation.


Applications are invited for this position from AHPRA registered medical practitioners with FRACS or equivalent and recognition as a Specialist in Psychiatry.

Contact: Dr Mandy Evans

Phone: 02 6205 0687

Apply now at

http://www.health.act.gov.au/employment

j1

 

Drug & Alcohol Review App

DAR Logo

 

The new Drug and Alcohol Review App is now available on both Android and iOS.

You can download it for Apple devices from iTunes here: https://itunes.apple.com/us/app/drug-and-alcohol-review/id1093133817?ls=1&mt=8

And for Android from the Google Play store here: https://play.google.com/store/apps/details?id=com.wiley.jas.dar

APSAD members can access content by clicking “I already have access” when prompted, and then “Through my society affiliation” which will bring them to the APSAD login page.

If you don't remember your password you can reset it by clicking here. If you don't remember your username then contact the office for the details.

 

Thoughts of Substance Podcast #2

Thoughts of Substance podcasts have been created by the APSAD Early Career Researcher sub-committee. 

In this episode, Dr Amy Peacock is joined by Dr Sarah Larney, winner of the 2014 Australasian Professional Society on Alcohol and Other Drugs (APSAD) Early Career Researcher Award. Dr Larney is a Senior Research Fellow at the National Drug and Alcohol Research Centre, conducting epidemiological research related to injecting drug use and related problems. In this episode, Dr Larney describes her career highs and lows, and offers tips for establishing international collaborations and building an academic social media presence.

Thought of Substance podcast slide

https://soundcloud.com/user-960069631-756237016/2-podcast-thought-of-substance

 

Save the date 2018 APSAD Conference

APSAD 2018 750x300

Kia ora

On behalf of the Australasian Professional Society on Alcohol and other Drugs, we are pleased to invite you to our beautiful City of Sails and fun, Auckland, for the APSAD Auckland 2018 Conference.

The Conference will be held at the Pullman Hotel in the centre of Auckland from 4 - 7 November. It will showcase high quality and state of the art scientific research into treatment, prevention and policy while also providing an opportunity for practitioners to share their latest insights and lessons learnt.  Where ever you have travelled from you will be warmly welcomed.

We will be sharing with you a uniquely Kiwi experience.  Auckland is a diverse city full of activities and surrounded by the breathtaking scenery! It’s the sort of place where sleep gets in the way! Exploring beyond Auckland will also be highly rewarding. And for those with a few extra days before or after the conference opportunities are endless - explore subtropical Northland and the Bay of Islands; the low rises of the Coromandel Peninsular; the magical Māori experience in Rotorua; our vibrant capital Wellington; or the breathtaking scenery of the Southern Alps. There’s plenty more!

On behalf of the APSAD Council, Organising Committee and the Scientific Advisory Committee we would be honoured to welcome you and your families/whanau to Auckland, New Zealand in 2018.

Dr Susanna Galea and Dr David Newcombe

2018 APSAD Conference Co-Convenors  

 

Opportunity to give your opinion on opioid consumption and take-home naloxone

The National Drug Research Institute (NDRI) is currently conducting a research project on the professional issues posed by opioids, overdose and take-home naloxone for people working in relevant areas.

We’re currently interviewing Victorian health professionals about their experiences with and knowledge of opioids, overdose and take-home naloxone.

We would like to interview:

  • Pharmacotherapy prescribers
  • Pain management specialists
  • General practitioners
  • Pharmacists

Participation involves a confidential audio recorded interview of about one hour. Compensation of a $75 gift voucher for your time is also available.

Interviews will be conducted in a location convenient to you.

 

For a project description and extra details please visit https://addictionconcepts.com/2017/09/26/now-recruiting-health-professionals

For additional information, or to participate in the study, please contact Dr Adrian Farrugia on 03 9079 2205 / 0467 633 751 or at: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Position Vacant | responsible for leading the development of addiction research across MARC

A significant opportunity to undertake the role of Associate Professor has arisen. In this role you will be expected to cultivate the highest standards within the Monash Addiction Research Centre (MARC).

MARC is a new Centre, established in 2017 in line with the Monash University Peninsula Campus Plan: Beyond 2016.  MARC brings together world-leading expertise from across Monash University to address the harms related to alcohol, drugs and gambling and related health and social problems.  The Centre will build a national response, through cutting edge epidemiology, neuroscience, innovative workforce and policy development, as well as novel treatment paradigms.  The Centre will focus on education and workforce development programs; research and research training; and policy and translation impact.

In this high profile role you will be responsible for leading the development of addiction research across MARC, as well as contributing to addiction and mental health teaching and research across Monash University. As the successful applicant you will also act as Deputy Director of the Centre and will work closely with health service, government and community partners.

Your ability to display leadership in the strategic development of grants and projects whilst working with a multidisciplinary team of researchers undertaking multiple complex projects will ensure not only your success but also that of the MARC. 

A generous research support package will be available to the selected applicant to support the development of addiction research at the Peninsula campus

Possession of a PhD or equivalent qualifications and research experience is essential in this role.

If you believe you can fulfil these requirements, you are strongly encouraged to apply.

This role is a full-time position; however, flexible working arrangements may be negotiated.

Your application must address the selection criteria. Please refer to "How to apply for Monash Jobs"

Enquiries
Professor Dan Lubman, This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Thoughts of Substance Podcast

The APSAD Early Career Researcher (ECR) subcommittee has been working on new initiatives which we hope the APSAD membership, particularly our ECRs, will find of interest. The subcommittee will be developing a series of podcasts under the title “Thoughts of Substance” where you can hear members of the ECR subcommittee interview professionals in the drug and alcohol sector discussing research, ideas and a range of other topics, across a range of disciplines, relevant for ECRs in this field. Over the next few episodes, you can hear from some of the previous winners of the APSAD Early Career Award discuss how their careers have evolved, and their current work. We are excited to announce the first Thoughts of Substance podcast has just been released featuring Dr Christina Marel interviewing Dr Suzanne Nielsen (APSAD ECR Award winner in 2011).

We would be happy to hear your thoughts and feedback, let us know if you have an idea or topic you would like to hear about by emailing This email address is being protected from spambots. You need JavaScript enabled to view it.

Join in the conversation with other ECRs on our APSAD ECR network Facebook Group page and our LinkedIn networking group.

Thought of Substance podcast slide

Thoughts of Substance Podcast #1

 

APSAD Media Release - Doctors strongly oppose Welfare Reform Bill and drug testing trial

Doctors from the Australasian Professional Society on Alcohol and other Drugs (APSAD) strongly oppose the Federal Government’s Welfare Reform Bill and its planned drug testing ‘trial’ for welfare recipients.

Chair of the APSAD Medical Special Interest Group, Dr Tony Gill, said the ‘trial’ will harm the health of people who use drugs, and waste a great deal of money that could be far better spent on providing voluntary treatment.

“Our Group represents addiction medicine specialists, general practitioners, psychiatrists and other doctors in the APSAD membership,” said Dr Gill, who is APSAD Vice President/President-Elect and has worked as a specialist in the alcohol and other drugs field for more than 25 years.

“As medical practitioners who work with patients with drug and alcohol-related problems, we are very clear that the drug testing ‘trial’ as currently planned is unworkable for numerous reasons.

  • The ‘trial’ is not supported by any scientific evidence, medical groups have not been consulted and have had no input into it, and it is widely opposed by relevant experts

  • Similar attempts have been found to be costly and/or unworkable in New Zealand, Canada, the USA and UK

  • The cost will be considerable, with few, if any, benefits

  • The ‘trial’ may result in people with significant health problems having reduced, or  in some cases no, access to income

  • The ‘trial’ will further widen the Gap of Health status for Aboriginal people

  • A ‘trial’ cannot be relevant to many parts of the nation as there are many areas, including rural and regional ones, with very few drug and alcohol services as well as  poor access to pathology services

  • Already there are not enough drug and alcohol services available in Australia to provide access to treatment for people who need them. Many people who currently want treatment face long waiting periods. This will be made worse by automatically referring

    in a whole lot of people who don’t need specialist treatment under the proposed ‘trial’
  • Some APSAD members believe the trial is unethical and may decide to refuse to participate.

“Problematic drug use should be treated as a health problem, not a reason for increasing stigma and reducing access to welfare,” Dr Gill said.

 “The causes of drug problems in individuals are complex. Effective treatment for people with drug problems and support for their families is the right approach, not increasing stigma towards people who use drugs. 

“The Federal Government’s planned ‘trial’ of drug testing for people receiving welfare payments is a bad idea.

“It makes no sense to spend so much money unnecessarily on something that doesn’t work,

when we know that treatment services are already chronically underfunded.

“This scheme would either rely on cheap tests that are inaccurate, in order to save money, or spend exorbitant costs on high quality yet still inconclusive testing.

“Furthermore, there is no evidence that it will actually assist people to get back to work,” he said.

 

Australasian Professional Society on Alcohol and other Drugs (APSAD)www.apsad.org.au

The Australasian Professional Society on Alcohol and other Drugsis the Asia Pacific's leading multidisciplinary organisation for professionals involved in the alcohol and other drug field. APSAD is dedicated to:

  • promoting evidence-based improvements in the treatment and prevention of drug and alcohol-related problems
  • raising awareness about the problems related to the use of alcohol and other drugs
  • promoting best standards in research in the drug and alcohol field
  • providing development and support to professionals working in the drug and alcohol field. 

Submission to the Senate Community Affairs Legislation Committee’s inquiry into Social Services Legislation Amendment (Welfare Reform) Bill 2017

APSAD is closely involved with the Royal Australasian College of Physicians (RACP), particularly with its Australasian Chapter of Addiction Medicine (AChAM).

APSAD formally supports the RACP’s submission to the Senate inquiry, which strongly opposes the measures contained in schedules 12, 13 and 14 of the Bill and urges they not be pursued. 

www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/WelfareReform/Submissions

 

Subcategories